who manufactures semaglutide Ozempic® (semaglutide) GLP-1 RA for

Several studies have evaluated how AOD-9604 affects the body in the context of weight loss

And while we do not prescribe or endorse the use of the brand name diabetes medication for weight loss, there is now an FDA-approved version of the drug that is prescribed for weight loss, and it is now part of our Miami-based medical weight loss programs

Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026

AACE comprehensive diabetes management algorithm 2013

Your Klinic care team can guide you through exploring all available options

Most common side effects of orforglipron In phase 2 and phase 3 trials, the most frequently reported side effects were: Nausea Diarrhoea Constipation Vomiting Indigestion/dyspepsia These usually appeared during dose escalation and often settled as the body adjusted